NRC — Microbial fermentation pilot plant facility research facility

Biotechnology companies often reach a critical point where promising lab results need to be proven at a larger, industry-relevant scale before commercialization or regulatory progress can move forward. For Canadian life sciences businesses without their own pilot-scale infrastructure, access to specialized facilities can make the difference between stalled development and a viable production process. The NRC — Microbial Fermentation Pilot Plant Facility offers that bridge, allowing companies to move from bench-scale experiments to semi-industrial production in a controlled, cGMP-compatible environment.

Operated by the National Research Council of Canada through its Human Health Therapeutics Research Centre, this national facility provides fee-for-service access to advanced microbial fermentation equipment and expert scientific support. Businesses can scale microbial processes up to roughly 1,500 litres while working alongside a multidisciplinary team experienced in bioprocess development, optimization, purification, and scale-up. The facility is particularly valuable for small and mid-sized biotech firms developing proteins, peptides, probiotics, nutraceuticals, or other biologically derived products that require robust process data and high-quality material for preclinical or technical validation.

Support is tailored to each project, with costs varying based on scope and technical requirements rather than fixed funding limits. For biotechnology companies looking to de-risk scale-up, validate manufacturing processes, or prepare for downstream production, this NRC facility can play a strategic role. Exploring the full details can help determine how this resource fits into your development roadmap.